skip to content

Read about our recent product expansion here.


View peer-reviewed publications, white
papers, and posters from the Color team
and our collaborators.

Peer-Reviewed Publications

Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology
(J Clin. Oncol., 2023)

Treatment for graduate students: Blunting the emotional toll of postgraduate education
(J Consult Clin Psychol., 2023)

From “surviving to thriving”: Mood Lifters – a wellness program for parents of medically complex children
(Palliat. Support Care, 2023)

Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer
In collaboration with GENTleMEN Study (JCO Precis Oncol, 2023)

The GC Immersive: Patching the pipeline with genetic counseling experiences for all
(Journal of Genetic Counseling, 2023)

Remotely Delivered Cancer Genetic Testing in the Making Genetic Testing Accessible (MAGENTA) Trial: A Randomized Clinical Trial
(JAMA Oncology, 2023)

Clinical Implementation of Combined Monogenic and Polygenic Risk Disclosure for Coronary Artery Disease
In collaboration with Amit Khera and Sek Kathiresan (JACC, 2022)

Harmonizing variant classification for return of results in the All of Us Research Program
In collaboration with the All of Us Research Program (Human Mutation, 2022)

Mood Lifters: evaluation of a novel peer-led mental wellness program
(Ment. Health Rev. J., 2022)

Digital health-enabled genomics: Opportunities and challenges
In collaboration with the All of Us Research Program and 23andMe (AJHG, 2022)

Whole genome sequencing as an investigational device for return of hereditary disease risk and pharmacogenomic results as part of the All of Us Research Program
In collaboration with the All of Us Research Program (Genome Medicine, 2022)

Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
In collaboration with UCSF and CDPH (Nature Microbiology, 2022)

Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study
(Cancer Prevention Research, 2021)

Model-driven mitigation measures for reopening schools during the COVID-19 pandemic
(PNAS, 2021)

Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps
(Nature Medicine, 2021)

Intronic Breakpoint Signatures Enhance Detection and Characterization of Clinically Relevant Germline Structural Variants
(Molecular Diagnostics, 2021)

Association of DNA variation with liver cirrhosis: a multi-trait genome-wide association and gene-environment interaction study 
(Gastroenterology, 2020)

Color Data v2: a user-friendly, open access database with hereditary cancer and hereditary cardiovascular conditions datasets 
Database (2020)

Association of genetic variation with cirrhosis: a multi-trait genome-wide association and gene-environment interaction study
Gastroenterology (2020)

Multiplexed measurement of variant abundance and activity reveals VKOR topology, active site and human variant impact
eLife (2020)

Prevalence of Inherited Mutations in Breast Cancer Predisposition Genes among Uganda and Cameroon Women
Cancer Epidemiology, Biomarkers & Prevention (2020)

Points to consider when assessing relationships during family-based clinical genomic testing: a statement of the American College of Medical Genetics and Genomics (ACMG)
Genetics in Medicine (2020)

Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions
Nature Communications (2020)

LEAP: Using machine learning to support variant classification in a clinical setting
Human Mutation (2020)

Patient acceptance of genetic testing for familial hypercholesterolemia in the CASCADE FH Registry
Journal of Clinical Lipidology (2020)

Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening
Cancer Medicine (2020)

The “All of Us” Research Program
New England Journal of Medicine (2019)

Ethnic disparities among men with prostate cancer undergoing germline testing
Urologic Oncology: Seminars and Original Investigations (2019)

Low coverage whole genome sequencing enables accurate assessment of common variants and calculation of genome-wide polygenic scores
Genome Medicine (2019)

Characterization of splice-altering mutations in inherited predisposition to cancer
PNAS (2019)

Assessment of blind predictions of the clinical significance of BRCA1 and BRCA2 variant
Human Mutation (2019)

Multi-Gene Panel Testing of 23,179 Individuals for Hereditary Cancer Risk Identifies Pathogenic Variant Carriers Missed by Current Genetic Testing Guidelines
Journal of Molecular Diagnostics (2019)

A scalable, aggregated genotypic–phenotypic database for human disease variation
Database (2019)

Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative
Journal of the National Cancer Institute (2019)

Identification of a novel GREM1 duplication in a patient with multiple colon polyps
Familial Cancer (2019)

Rare TP53 variant associated with Li-Fraumeni syndrome exhibits variable penetrance in a Saudi family
npj Genomic Medicine (2018)

A machine learning model to determine the accuracy of variant calls in capture-based next generation sequencing
BMC Genomics (2018)

Scaling resolution of variant classification differences in ClinVar between 41 clinical laboratories through an outlier approach
Human Mutation (2018)

ClinVar database of global familial hypercholesterolemia-associated DNA variants
Human Mutation (2018)

Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines: A Joint Recommendation of the Association for Molecular Pathology and the College of American Pathologists
Journal of Molecular Diagnostics (2018)

Inherited predisposition to breast and ovarian cancer in non-Jewish populations in Israel
Breast Cancer Research and Treatment (2017)

Multi-gene Panel Testing For Hereditary Cancer Predisposition In Unsolved High Risk Breast And Ovarian Cancer Patients
Breast Cancer Research and Treatment (2017)

Technical Papers

Color’s HPV Test for Cervical Cancer Screening

Hereditary Cancer Genetic Test

Hereditary High Cholesterol Genetic Test

Hereditary Heart Health Genetic Test

Medication Response Genetic Test

Color’s Protocol for LAMP Diagnostic Assay

Return to On-Site SARS-CoV-2 Testing Protocols

Color’s Genome-wide Polygenic Score Validation

SARS-CoV-2: Tracking Variants of Concern

Color Pooled Sample Testing

Color Genome-wide Polygenic Score

Research Posters

Cancer Care


Virtual Cancer Clinic Drives Increased Adherence to Guidelines
IFEBP Art & Science of Health Promotion 2024

Free Resource

The Population Genomics Platform Playbook

A guide to build and scale a population genomics program in your health system.